Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam

Journal of Drugs in Dermatology

Volumn 8, Issue 3, 2009, Pages 299-304

  Trumbore, Mark W ^a   Goldstein, Jay A ^b   Gurge, Ronald M ^a  

^a Product Research and Development   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; SODIUM SULFACETAMIDE PLUS SULFUR; UNCLASSIFIED DRUG; DERMATOLOGICAL AGENT; SULFACETAMIDE; SULFUR; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; PAPULE; PAPULOPUSTULAR ROSACEA; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDY; PRURITUS; PUSTULE; QUALITY OF LIFE; ROSACEA; TELANGIECTASIA; TREATMENT DURATION; TREATMENT OUTCOME; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; EMOLLIENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; ROSACEA; SULFACETAMIDE; SULFUR;

EID: 63249115467     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board Fam Pract. 2002;15(3):214-217.
2. Blount BW, Pelletier AL. Rosacea: A common, yet commonly overlooked, condition. Am Fam Physician. 2002;66(3):435-440.
3. Diamantis S, Waldorf HA. Rosacea: Clinical presentation and pathophysiology. J Drugs Dermatol. 2006;5(1):8-12.
4. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587.
5. Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2004;50(6):907-912. (Pubitemid 38685771)
6. Laquieze S, Czernielewski J, Baltas E. Beneficial use of Cetaphil Moisturizing Cream as a part of a daily skin care regimen for individuals with rosacea. J Dermatol Treat. 2007;18(3):158-162. (Pubitemid 46854831)
7. International Rosacea Foundation The acne factor. Available at http://www.internationalrosaceafoundation.org/acne-factor.php4. Accessed August 16, 2008.
8. Millikan L. The proposed inflammatory pathophysiology of rosacea: Implications for treatment. Skinmed. 2003;2(1):43-47.
9. Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. British Journal of Dermatology. 2007;157(3)474-481. (Pubitemid 47256121)
10. Nally JB, Berson DS. Topical therapies for rosacea. J Drugs Dermatol. 2006;5(1):23-26.
11. Torok HM, Webster G, Dunlap FE, et al. Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. Cutis. 2005;75(6):357-363. (Pubitemid 40905319)
12. Wolf JE. Present and future rosacea therapy. Cutis. 2005;75(suppl 3):4-7.
13. Del Rosso JQ. Evaluating the role of topical therapies in the management of rosacea: Focus on combination sodium sulfacetamide and sulfur combinations. Cutis. 2004;73(suppl 1):29-33. (Pubitemid 38167894)
14. Olansky S. Old drug-in a new system-revisited. Cutis. 1977;19(6):852-854.
15. Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol. 2004;3(4):427-431.
16. IMS Health. Xponent Report. USC 37120. July 2008.
17. Clarifoam™ [prescribing information]. Cumberland, RI: Onset Therapeutics; 2006.
18. Trumbore M. The moisturization ability of a sodium sulfacetamide (10%)/sulfur (5%) emollient foam. Abstract presented T: Meeting of American Academy of Dermatology; July 30-August 3, 2008; Chicago, IL. AB21 Abstract P13.
19. Trumbore, MW.,Gurge RM, Hirsh JC, inventors; Collegium Pharmaceutical Inc, assignee. Topical Pharmaceutical Foam Compositiion. United States Patent Application 20070154402, July 5, 2007.
20. Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007; 57(2):213-221. (Pubitemid 47053981)